Director, Communications & Patient Advocacy - Therapy Area Lead

Key Responsibilities:

• Lead transition of pipeline assets for the respective TA from Science and Innovation Communications and Development Patient Engagement to International TA, including oversight of up to date global and top-country launch sequence and strategy implementation.

• Development and co-creation of TA communication and patient advocacy strategies, KPIs and measurement with Germany, China, Japan and advising in strategy, tracking, implementation and performance management of TA/product brand strategy to other top-11 markets.

• Ensuring systemic implementation of OGSM framework and A&I measures to consistently monitor TA and predict performance management above country and for Top 11 market, in alignment with CA Strategy and Operations and in partnership with Public Affairs.

• Establish strategic and ongoing relationships with internal and external stakeholders, leading to business-aligned, long-term collaborations that are valued by and valuable for key audiences, and most importantly, patients.

• Represent function on respective Therapy Area Leadership Team and become trusted strategic business partner to TA Head. Providing insights and counsel on the external TA and product environment including the latest communications channels/trends/stakeholder insights.

• Support talent management and growth for International TA Comms & Patient Advocacy team members, removing barriers and creating a great place to work enabling agile and iterative execution.

• Accountability for securing budget and budget management of respective TA strategies by CLS and Corporate Affairs. Including governance and compliance of Patient Advocacy grants, sponsorships and TOV reporting, supported by the Patient Advocacy governance lead.

• Supervise media relations strategy and implementation, including relationships with media customers, for respective TA in coordination with Corporate Media Relations.

• Ensure strong partnership with Policy Public Affairs to develop integrated OGSM frameworks for therapy areas to support TA/brand policy, strategies, and tactics.

• Implement internal communications for key brand milestones and launch activities in coordination with ED President Corp Affairs.

Essential  Requirements:

• Bachelor’s degree or other qualification.

• Many years’ experiences in diversified communications, patient advocacy and patient relations.

• Demonstrated therapeutic experience.

• Product PR communications, social media strategy and implementation.

• Corporate communications, IR, media relations, stakeholder relations, policy.

• Industry/ Business exposure in matrixed organisation.

• Leading large and/or diverse multi-functional teams.

• Exemplifies and drives a predictive approach; seeks multidirectional insights to understand our environments and customers, and embraces iterative, measurable experimentation and action.

• Crisis, issues and agency management.

• Validated ability to cultivate impactful teams - team leadership and management.

• Ability to prioritise and maximise resources.

• Business and organisational awareness, enterprise perspective.

Benefits and rewards:

Read our handbook to learn about all the ways we’ll help you thrive personally and professionally:

https://www.novartis.com/careers/benefits-rewards

Commitment to Diversity & Inclusion:

We are committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.

Accessibility and accommodation:

Novartis is committed to working with and providing reasonable accommodation to all individuals. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the recruitment process, or in any order to receive more detailed information about essential functions of a position, please send an e-mail to inclusion.switzerland@novartis.com and let us know the nature of your request and your contact information. Please include the job requisition number in your message.